What an honor! Nancy Sander, AANMA President and Founder, will help Cephalon‘s CEO, Kevin Buch, ring the NASDAQ opening bell on Monday, April 25, 2011 at 9:30 AM! Cephalon, a biopharmaceutical research and development company, is celebrating 20 years of trading on the NASDAQ. Cephalon is committed to improving patient quality of life and shares AANMA’s mission to eliminate death and suffering due to asthma, allergies, and related conditions. Watch live on CNBC, Bloomberg TV, or Reuters TV starting at 9:15 AM!